Evidence map›Paper›PMID 33162992›Full record

ArticleFrontiers in immunology2020

Clinical Significance of Serum Soluble TNF Receptor I/II Ratio for the Differential Diagnosis of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome From Other Autoinflammatory Diseases.

Junko Yasumura, Masaki Shimizu, Tomoko Toma, Masato Yashiro, Akihiro Yachie, Satoshi Okada

Open access · goldAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Protective Effect ofFrontiers in genetics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Junko YasumuraDepartment of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Masaki ShimizuDepartment of Pediatrics, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Tomoko TomaDepartment of Pediatrics, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Masato YashiroDepartment of Pediatrics, Okayama University Hospital, Okayama, Japan.
Akihiro YachieDepartment of Pediatrics, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Satoshi OkadaDepartment of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Kanazawa University · JPHiroshima University · JPOkayama University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Enzyme-Linked Immunosorbent AssayAdolescentAdultBiomarkersCase-Control StudiesChildChild, PreschoolDiagnosis, DifferentialFamilial Mediterranean FeverFemaleFeverHereditary Autoinflammatory DiseasesHumansHyaline Fibromatosis SyndromeInfantInfant, NewbornBiomarkersReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IITNFRSF1A protein, humanTNFRSF1B protein, humanfamilial Mediterranean feverKawasaki disease (KD)soluble tumor necrosis factor receptorsystemic juvenile idiopathic arthritis (sJIA)tumor necrosis factor receptor associated periodic syndrome (TRAPS)

Identifiers

PMID33162992
PMCPMC7591697
OpenAlexW3093455552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.